Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-20

Clinical Trial Update: A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in patients with neuropathic pain from post-herpetic neuralgia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: XenoPort, Inc. | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: COMPLETED | Results posted: 2011-05-20